Tag: <span>Mesothelioma News</span>

Targovax submits a study of its adenovirus based immune therapy…

Targovax has submitted a study protocol to the regulatory authorities in Spain to assess its ONCOS-102 product in combination with chemotherapy in patients with malignant pleural mesothelioma , a rare type of lung cancer associated with exposure to asb…